H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 45 Citations 6,327 89 World Ranking 3197 National Ranking 1502

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibody
  • Immune system
  • Bacteria

Stanley J. Cryz mostly deals with Vaccination, Immunology, Cholera vaccine, Cholera and Virology. As a part of the same scientific family, he mostly works in the field of Vaccination, focusing on Immunity and, on occasion, Ty21a. His study in Immunogenicity, Titer and Seroconversion is carried out as part of his Immunology studies.

His biological study spans a wide range of topics, including Internal medicine, Cholera toxin and Vibrio cholerae. His Virology study frequently links to other fields, such as Microbiology. The study incorporates disciplines such as Pseudomonas aeruginosa, Elastase and Antigen in addition to Microbiology.

His most cited work include:

  • Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. (267 citations)
  • Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. (252 citations)
  • Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. (186 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Immunology, Virology, Microbiology, Antibody and Vaccination. Stanley J. Cryz has included themes like Internal medicine and Cholera vaccine in his Immunology study. Stanley J. Cryz interconnects Virosome, Ty21a, Salmonella typhi and Immune system in the investigation of issues within Virology.

His research integrates issues of Antigen, Pseudomonas aeruginosa, Klebsiella, Monoclonal antibody and Conjugate vaccine in his study of Microbiology. The Antibody study combines topics in areas such as Serotype and Bacteria. His study looks at the relationship between Vaccination and fields such as Cholera, as well as how they intersect with chemical problems.

He most often published in these fields:

  • Immunology (47.83%)
  • Virology (40.00%)
  • Microbiology (39.13%)

What were the highlights of his more recent work (between 1997-2020)?

  • Immunology (47.83%)
  • Vaccination (32.17%)
  • Virology (40.00%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Immunology, Vaccination, Virology, Internal medicine and Rotavirus. In general Immunology, his work in Seroconversion, Antibody, Tetanus and Immunogenicity is often linked to Cyclophosphamide linking many areas of study. The concepts of his Vaccination study are interwoven with issues in Vibrio cholerae, Cholera vaccine, Booster dose and Ty21a.

His studies in Vibrio cholerae integrate themes in fields like Cholera and Diarrhea. His Ty21a research is multidisciplinary, incorporating elements of Immunization and Typhoid fever, Microbiology. His biological study spans a wide range of topics, including Bacterial vaccine and Monoclonal antibody.

Between 1997 and 2020, his most popular works were:

  • Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. (186 citations)
  • Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. (181 citations)
  • Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. (138 citations)

In his most recent research, the most cited papers focused on:

  • Antibody
  • Immune system
  • Bacteria

The scientist’s investigation covers issues in Vaccination, Immunology, Seroconversion, Internal medicine and Virology. His work focuses on many connections between Vaccination and other disciplines, such as Cholera vaccine, that overlap with his field of interest in Ty21a. His Immunology study is mostly concerned with Virosome and Measles virus.

The study incorporates disciplines such as Mumps vaccine, Antibody titer, Immunoglobulin G, Immunity and Microbiology in addition to Seroconversion. His research in Antibody titer intersects with topics in Booster dose, Hemagglutination assay, Influenza vaccine and Immunogenicity. His Internal medicine research incorporates elements of El Tor, Vibrio cholerae, Cholera and Vaccine efficacy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

MyronM. Levine;Deirdre Herrington;Genevieve Losonsky;Ben Tall.
The Lancet (1988)

387 Citations

Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.

D E Ohman;S J Cryz;B H Iglewski.
Journal of Bacteriology (1980)

383 Citations

Immunogenicity of new virosome influenza vaccine in elderly people.

R Glück;R Mischler;B Finkel;J.U Que.
The Lancet (1994)

264 Citations

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.

Emily Richie;Narain H Punjabi;Yuwono Sidharta;Kenny Peetosutan.
Vaccine (2000)

263 Citations

Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

D E Woods;S J Cryz;R L Friedman;B H Iglewski.
Infection and Immunity (1982)

251 Citations

Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Carol O. Tacket;Mitchell B. Cohen;Steven S. Wasserman;Genevieve Losonsky.
Infection and Immunity (1999)

209 Citations

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

Myron M. Levine;Catterine Ferreccio;Paulina Abrego;Oriana San Martin.
Vaccine (1999)

193 Citations

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

Deirdre A. Herrington;Lillian Van De Verg;Samuel B. Formal;Thomas L. Hale.
Vaccine (1990)

184 Citations

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

C Ferreccio;E Ortiz;S Cryz;M.M Levine.
The Lancet (1990)

184 Citations

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.

Suharyono;C Simanjuntak;H Totosudirjo;N Witham.
The Lancet (1992)

180 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stanley J. Cryz

Myron M. Levine

Myron M. Levine

University of Maryland, Baltimore

Publications: 114

Marcelo B. Sztein

Marcelo B. Sztein

University of Maryland, Baltimore

Publications: 45

John D. Clemens

John D. Clemens

International Centre for Diarrhoeal Disease Research

Publications: 37

Stephen B. Calderwood

Stephen B. Calderwood

Massachusetts General Hospital

Publications: 36

Edward T. Ryan

Edward T. Ryan

Harvard University

Publications: 36

Firdausi Qadri

Firdausi Qadri

International Centre for Diarrhoeal Disease Research

Publications: 35

Barbara H. Iglewski

Barbara H. Iglewski

University of Rochester

Publications: 30

Niels Høiby

Niels Høiby

University of Copenhagen

Publications: 28

Alan S. Cross

Alan S. Cross

University of Maryland, Baltimore

Publications: 28

Marcela F. Pasetti

Marcela F. Pasetti

University of Maryland, Baltimore

Publications: 28

John J. Mekalanos

John J. Mekalanos

Harvard University

Publications: 28

Gerald B. Pier

Gerald B. Pier

Brigham and Women's Hospital

Publications: 27

Jason B. Harris

Jason B. Harris

Harvard University

Publications: 24

Karen L. Kotloff

Karen L. Kotloff

University of Maryland, Baltimore

Publications: 23

Andrew J. Pollard

Andrew J. Pollard

University of Oxford

Publications: 22

James B. Kaper

James B. Kaper

University of Maryland, Baltimore

Publications: 21

Something went wrong. Please try again later.